Skip to main content

Axsome Therapeutics, Inc. (NASDAQ: AXSM) Investor Securities Class Action Lawsuit 05/13/2022

  • If you purchased a significant amount of shares of Axsome Therapeutics, Inc. (NASDAQ: AXSM) between December 30, 2019 and April 22, 2022, and / or if you purchased any NASDAQ: AXSM shares prior to December 2019 and continue to hold any of those shares, you have certain options and for certain investors are short and strict deadlines running. Deadline: July 12, 2022. NASDAQ: AXSM investors should contact the Shareholders Foundation, Inc.

  • To have your information reviewed for options and to receive notifications about this case, please send an email to mail@shareholdersfoundation.com, or call us at (858) 779-1554.

Site Members can sign up for company wide alerts

Lawsuit Overview

September 25, 2023 - The court issued an order granting the motion to dismiss. Leave was given to seek to file another amended complaint. December 16, 2022 - A motion was filed to dismiss the amended complaint. October 7, 2022 - An amended complaint was filed. May 13, 2022 - An investor in shares of Axsome Therapeutics, Inc. (NASDAQ: AXSM) filed a lawsuit in the U.S. District Court fo...



You must register (for free) or login to view the entire case.